Yang Pan

906 total citations
35 papers, 729 citations indexed

About

Yang Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yang Pan has authored 35 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Yang Pan's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Yang Pan is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). Yang Pan collaborates with scholars based in China, Macao and United States. Yang Pan's co-authors include Gang Su, Tao Li, Hongjie Wang, Xiaorong Li, Zhimin Du, Pengzhou Hang, Lihui Zhao, Jingjing Du, Yuyang Zheng and Qidong You and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Scientific Reports.

In The Last Decade

Yang Pan

34 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Pan China 14 498 261 88 64 58 35 729
Xuyu Zu China 18 617 1.2× 305 1.2× 43 0.5× 47 0.7× 60 1.0× 35 1.1k
Xiaonan Zhu China 18 450 0.9× 180 0.7× 19 0.2× 49 0.8× 30 0.5× 40 768
Birgit Honrath Germany 13 435 0.9× 91 0.3× 33 0.4× 118 1.8× 86 1.5× 16 678
Yunyun Qin China 12 531 1.1× 370 1.4× 26 0.3× 52 0.8× 71 1.2× 16 787
Yi Luan China 15 334 0.7× 78 0.3× 54 0.6× 31 0.5× 96 1.7× 27 545
Chotiros Daosukho United States 12 316 0.6× 104 0.4× 95 1.1× 36 0.6× 36 0.6× 13 579
Aling Dong United States 14 920 1.8× 93 0.4× 55 0.6× 37 0.6× 68 1.2× 16 1.3k
Liwu Fu China 6 521 1.0× 173 0.7× 20 0.2× 54 0.8× 37 0.6× 8 772

Countries citing papers authored by Yang Pan

Since Specialization
Citations

This map shows the geographic impact of Yang Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Pan more than expected).

Fields of papers citing papers by Yang Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Pan. The network helps show where Yang Pan may publish in the future.

Co-authorship network of co-authors of Yang Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Pan. A scholar is included among the top collaborators of Yang Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Pan. Yang Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Shuo, Yang Pan, Siqi Zhang, et al.. (2025). Multicyclic Peptides Targeting PD-L1 for Radiotheranostics: From Discovery to Clinical Proof-of-Concept. Journal of the American Chemical Society. 147(39). 35638–35654. 2 indexed citations
2.
Pan, Yang, Xiaoling Chen, Hao Wen, et al.. (2025). In vitro differentiation of common lymphoid progenitor cells into B cell using stromal cell free culture system. BMC Immunology. 26(1). 12–12.
3.
Wang, Jin, et al.. (2024). Combination of circulating tumor cells and 18F‐FDG PET/CT for precision diagnosis in patients with non‐small cell lung cancer. Cancer Medicine. 13(18). e70216–e70216. 3 indexed citations
4.
Pan, Yang, et al.. (2021). MicroRNA-98 ameliorates doxorubicin-induced cardiotoxicity via regulating caspase-8 dependent Fas/RIP3 pathway. Environmental Toxicology and Pharmacology. 85. 103624–103624. 12 indexed citations
5.
6.
Chen, Wen, Weiwei Zhang, Yang Pan, Chang Liu, & Shu‐Li Shao. (2020). [Effects of Toosendanin on the formation of CTPS cytoophidium in human gastric cancer cell MKN-45 and its mechanism].. PubMed. 36(6). 633–636. 1 indexed citations
7.
Chen, Hualin, et al.. (2020). Three-gene prognostic biomarkers for seminoma identified by weighted gene co-expression network analysis. PLoS ONE. 15(10). e0240943–e0240943. 4 indexed citations
8.
Zhu, Yunxiao, Ziyi Yang, Han Chen, et al.. (2020). <p>lncRNAHIF1A-AS2 Promotes Renal Carcinoma Cell Proliferation and Migration via miR-130a-5p/ERBB2 Pathway</p>. OncoTargets and Therapy. Volume 13. 9807–9820. 6 indexed citations
9.
Du, Jingjing, Pengzhou Hang, Yang Pan, et al.. (2019). Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Toxicology and Applied Pharmacology. 369. 73–81. 63 indexed citations
10.
Zhao, Jing, Jingjing Du, Yang Pan, et al.. (2018). Activation of cardiac TrkB receptor by its small molecular agonist 7,8-dihydroxyflavone inhibits doxorubicin-induced cardiotoxicity via enhancing mitochondrial oxidative phosphorylation. Free Radical Biology and Medicine. 130. 557–567. 42 indexed citations
11.
Sun, Jie, et al.. (2018). Isometric Contractility Measurement of the Mouse Mesenteric Artery Using Wire Myography. Journal of Visualized Experiments. 12 indexed citations
12.
Pan, Yang, et al.. (2016). Clinical and Prognostic Significance of ANCCA in Squamous Cell Lung Carcinoma Patients. Archives of Medical Research. 47(2). 89–95. 6 indexed citations
13.
Wang, Hongjie, et al.. (2015). Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumor Biology. 36(5). 3355–3359. 146 indexed citations
14.
Hao, Ting, et al.. (2015). Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer. Molecular and Cellular Biochemistry. 402(1-2). 75–82. 39 indexed citations
15.
Jiang, Zhengyu, Lili Xu, Mengchen Lu, et al.. (2014). Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis. Journal of Computer-Aided Molecular Design. 28(12). 1233–1245. 25 indexed citations
16.
Lu, Jie, Liang Wu, Teng Jiang, et al.. (2014). Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells. Neurotoxicology and Teratology. 47. 16–24. 35 indexed citations
17.
Xu, Xiaoli, Haopeng Sun, Fang Liu, et al.. (2014). Discovery and Bioevaluation of Novel Pyrazolopyrimidine Analogs as Competitive Hsp90 Inhibitors Through Shape‐Based Similarity Screening. Molecular Informatics. 33(4). 293–306. 3 indexed citations
18.
19.
Sun, Haopeng, Jianmin Jia, Fen Jiang, et al.. (2014). Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening. European Journal of Medicinal Chemistry. 79. 399–412. 33 indexed citations
20.
Pan, Yang. (2011). CLUSTER ANALYSIS AND CODON USAGE BIAS STUDIES ON psbA GENES FROM 11 PLANT SPECIES. Journal of Nuclear Agricultural Sciences. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuyu Zu Breakdown of academic impact, for papers by Xiaonan Zhu Breakdown of academic impact, for papers by Birgit Honrath Breakdown of academic impact, for papers by Yunyun Qin Breakdown of academic impact, for papers by Yi Luan Breakdown of academic impact, for papers by Chotiros Daosukho Breakdown of academic impact, for papers by Aling Dong Breakdown of academic impact, for papers by Liwu Fu
Rankless by CCL
2026